Schibano Pharma

Schibano Pharma is a Swiss pharmaceutical company specializing in the development, production, and distribution of high-quality active pharmaceutical ingredients (APIs) and finished medicinal products. The company has a significant focus on the medical cannabis sector, utilizing advanced extraction and purification technologies to produce standardized cannabinoid-based therapies. Operating out of Steinhausen, Switzerland, Schibano Pharma provides CDMO services, including formulation development and GMP-compliant manufacturing for global partners. Their portfolio aims to address unmet needs in pain management and neurological disorders through rigorous Swiss quality standards. The company is fully licensed by Swissmedic for the handling and processing of controlled substances.